Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema

Table 4 Median change in best corrected visual acuity and central macular thickness according to the diabetic macular edema subtype diagnosed at baseline. P values were calculated using the Kruskal-Wallis test (statistical significance *P < 0.05)

BCVA best corrected visual acuity, DME diabetic macular edema, DRT diffuse retinal thickness, CME cystoid macular edema, SRD serous retinal detachment, CMT central macular thickness
¹Letters in the Early Treatment Diabetic Retinopathy Study (ETDRS) charts
^*Significantly different from DRT (p < 0.05)

ISSN: 1471-2415